Výsledky vyhledávání - "David, Yocum"

Using extremity magnetic resonance imaging to assess and monitor early rheumatoid arthritis: the optimal joint combination to be scanned in clinical practice

Autor: Ewa, Olech, Jane E, Freeston, Philip G, Conaghan, Elizabeth M A, Hensor, Paul, Emery, David, Yocum

Publikováno v: The Journal of rheumatology. 35(4)

To identify the optimal combination for detecting erosions in early rheumatoid arthritis using extremity magnetic resonance imaging (eMRI).In 44 patients, eMRI of 1 hand identified 77% who were erosive, 2 hands 89%, and 2 hands and feet 91%.eMRI iden

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e81bfa435444366afd5d9257eb56698c
https://pubmed.ncbi.nlm.nih.gov/18322995

Zobrazit plný text záznamu

Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0

Autor: Thasia, Woodworth, Daniel E, Furst, Rieke, Alten, Clifton O, Bingham, Clifton, Bingham, David, Yocum, Victor, Sloan, Wayne, Tsuji, Randall, Stevens, James, Fries, James, Witter, Kent, Johnson, Marissa, Lassere, Peter, Brooks

Publikováno v: The Journal of rheumatology. 34(6)

The OMERACT Drug Safety Working Group focuses on standardization of assessment and reporting of adverse events in clinical trials and longitudinal and observational studies in rheumatology. This group developed the Rheumatology Common Toxicity Criter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ef3418af68862003e3f275151a31388d
https://pubmed.ncbi.nlm.nih.gov/17552067

Zobrazit plný text záznamu

Effective use of TNF antagonists

Autor: David, Yocum

Publikováno v: Arthritis Research & Therapy

Tumor necrosis factor (TNF) antagonists are biologic response modifiers that have significantly improved functional outcomes in patients with rheumatoid arthritis (RA). RA is a progressive disease in which structural joint damage can continue to deve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2081ecb24183b4bf984207d1d7c90977
https://pubmed.ncbi.nlm.nih.gov/15228618

Zobrazit plný text záznamu

CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis

Autor: Ursula, Mason, Jose, Aldrich, Ferdinand, Breedveld, Charles B, Davis, Michael, Elliott, Mildred, Jackson, Christian, Jorgensen, Edward, Keystone, Robert, Levy, John, Tesser, Mark, Totoritis, Alemseged, Truneh, Michael, Weisman, Craig, Wiesenhutter, David, Yocum, Jin, Zhu

Publikováno v: The Journal of rheumatology. 29(2)

Double blind studies were conducted with the anti-CD4 monoclonal antibody (Mab) keliximab in patients with active, stable rheumatoid arthritis (RA), to confirm preliminary evidence of efficacy and safety from open. uncontrolled studies.We enrolled 13

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::513a64d144b7339b7075667e253d05d0
https://pubmed.ncbi.nlm.nih.gov/11838838

Zobrazit plný text záznamu

Health status and disease activity in systemic lupus erythematosus

Autor: Clare Hastings, Cheryl Yarboro, Kathleen Joyce, And David Yocum, Carole Berkebile

Publikováno v: Arthritis Care & Research. 2:65-69

The physical manifestations of disease activity and health status of patients with systematic lupus erythematosus (SLE) were measured in this study. Forty-nine patients completed the Arthritis Impact Measurement Scale (AIMS) and consented to examinat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e651243a192e4c0d3fd96d062f5e95bc
https://doi.org/10.1002/anr.1790020208

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání